222 related articles for article (PubMed ID: 24143997)
1. COPD symptoms in the morning: impact, evaluation and management.
Roche N; Chavannes NH; Miravitlles M
Respir Res; 2013 Oct; 14(1):112. PubMed ID: 24143997
[TBL] [Abstract][Full Text] [Related]
2. Development of the chronic obstructive pulmonary disease morning symptom diary (COPD-MSD).
Globe G; Currie B; Leidy NK; Jones P; Mannino D; Martinez F; Klekotka P; O'Quinn S; Karlsson N; Wiklund I
Health Qual Life Outcomes; 2016 Jul; 14(1):104. PubMed ID: 27424173
[TBL] [Abstract][Full Text] [Related]
3. Impact and factors associated with nighttime and early morning symptoms among patients with chronic obstructive pulmonary disease.
Stephenson JJ; Cai Q; Mocarski M; Tan H; Doshi JA; Sullivan SD
Int J Chron Obstruct Pulmon Dis; 2015; 10():577-86. PubMed ID: 25844033
[TBL] [Abstract][Full Text] [Related]
4. Patient's perception of symptoms related to morning activity in chronic obstructive pulmonary disease: the SYMBOL Study.
Kim YJ; Lee BK; Jung CY; Jeon YJ; Hyun DS; Kim KC; Yu SK; Choi HS; Shin WH; Lee KH
Korean J Intern Med; 2012 Dec; 27(4):426-35. PubMed ID: 23269884
[TBL] [Abstract][Full Text] [Related]
5. Real world COPD: association of morning symptoms with clinical and patient reported outcomes.
Roche N; Small M; Broomfield S; Higgins V; Pollard R
COPD; 2013 Dec; 10(6):679-86. PubMed ID: 24127914
[TBL] [Abstract][Full Text] [Related]
6. A cross-sectional observational study to investigate daily symptom variability, effects of symptom on morning activities and therapeutic expectations of patients and physicians in COPD-SUNRISE study.
Kuyucu T; Güçlü SZ; Saylan B; Demir C; Senol T; Güner S; Koyuncu E; Ozen F; Oztürk S; Cangül Z; Ağanoğlu S; Ozkaya S; Ocak SC; Akkurt H; Intepe YS; Bayrak MG; Güler T; Bekçi TT; Soyyiğit S; Seyfettin S; Kula O; Akbay MO; Büyükgöze B; Asal G; Başlilar S; Oztürk O;
Tuberk Toraks; 2011; 59(4):328-39. PubMed ID: 22233302
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the impact of morning symptoms in COPD using the Capacity of Daily Living during the Morning (CDLM) questionnaire.
Núñez A; Esquinas C; Barrecheguren M; Calle M; Casamor R; Miravitlles M
Int J Chron Obstruct Pulmon Dis; 2018; 13():3837-3844. PubMed ID: 30538445
[TBL] [Abstract][Full Text] [Related]
8. Daytime symptoms of chronic obstructive pulmonary disease: a systematic review.
Tsiligianni I; Kocks JWH
NPJ Prim Care Respir Med; 2020 Feb; 30(1):6. PubMed ID: 32081967
[TBL] [Abstract][Full Text] [Related]
9. [The influence of treatment with formoterol, formoterol with tiotropium, formoterol with inhaled glucocorticosteroid and tiotropium on lung functions, tolerance of exercise and simple, morning everyday activities in patients with chronic obstructive pulmonary disease (COPD)].
Szmidt M
Pneumonol Alergol Pol; 2012; 80(3):255-62. PubMed ID: 22562275
[TBL] [Abstract][Full Text] [Related]
10. The impact of morning symptoms on daily activities in chronic obstructive pulmonary disease.
O'Hagan P; Chavannes NH
Curr Med Res Opin; 2014 Feb; 30(2):301-14. PubMed ID: 24195740
[TBL] [Abstract][Full Text] [Related]
11. Understanding the impact of symptoms on the burden of COPD.
Miravitlles M; Ribera A
Respir Res; 2017 Apr; 18(1):67. PubMed ID: 28431503
[TBL] [Abstract][Full Text] [Related]
12. Morning symptoms in COPD: a treatable yet often overlooked factor.
van Buul AR; Kasteleyn MJ; Chavannes NH; Taube C
Expert Rev Respir Med; 2017 Apr; 11(4):311-322. PubMed ID: 28282500
[TBL] [Abstract][Full Text] [Related]
13. [Advances in study of early morning symptoms of chronic obstructive pulmonary disease].
Sun T; Chen P
Zhonghua Jie He He Hu Xi Za Zhi; 2022 May; 45(5):498-501. PubMed ID: 35527465
[TBL] [Abstract][Full Text] [Related]
14. Impact of night-time symptoms in COPD: a real-world study in five European countries.
Price D; Small M; Milligan G; Higgins V; Gil EG; Estruch J
Int J Chron Obstruct Pulmon Dis; 2013; 8():595-603. PubMed ID: 24348032
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of the Capacity of Daily Living during the Morning questionnaire and the Global Chest Symptoms Questionnaire in COPD.
Partridge MR; Miravitlles M; Ståhl E; Karlsson N; Svensson K; Welte T
Eur Respir J; 2010 Jul; 36(1):96-104. PubMed ID: 19897551
[TBL] [Abstract][Full Text] [Related]
16. The variability of respiratory symptoms and associated factors in COPD.
Miravitlles M; Izquierdo JL; Esquinas C; Pérez M; Calle M; López-Campos JL; Rodríguez González-Moro JM; Casanova C; Esteban C; de Lucas P
Respir Med; 2017 Aug; 129():165-172. PubMed ID: 28732827
[TBL] [Abstract][Full Text] [Related]
17. Early bronchodilator action of glycopyrronium versus tiotropium in moderate-to-severe COPD patients: a cross-over blinded randomized study (Symptoms and Pulmonary function in the moRnING).
Marin JM; Beeh KM; Clemens A; Castellani W; Schaper L; Saralaya D; Gunstone A; Casamor R; Kostikas K; Aalamian-Mattheis M
Int J Chron Obstruct Pulmon Dis; 2016; 11():1425-34. PubMed ID: 27418815
[TBL] [Abstract][Full Text] [Related]
18. Symptom variability in COPD: a narrative review.
Lopez-Campos JL; Calero C; Quintana-Gallego E
Int J Chron Obstruct Pulmon Dis; 2013; 8():231-8. PubMed ID: 23687444
[TBL] [Abstract][Full Text] [Related]
19. The association between objectively measured physical activity and morning symptoms in COPD.
van Buul AR; Kasteleyn MJ; Chavannes NH; Taube C
Int J Chron Obstruct Pulmon Dis; 2017; 12():2831-2840. PubMed ID: 29042764
[TBL] [Abstract][Full Text] [Related]
20. Symptom variability and control in COPD: Advantages of dual bronchodilation therapy.
Di Marco F; Santus P; Scichilone N; Solidoro P; Contoli M; Braido F; Corsico AG
Respir Med; 2017 Apr; 125():49-56. PubMed ID: 28340862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
